Abzena PLC

Abzena PLC
Stock Exchange London Stock Exchange
Market Cap
GBP33.74 M
Shares Outstanding
214.22 M
Public Float
170.33 M


Babraham Research Campus
Cambridge Cambridgeshire CB22 3AT
United Kingdom
Employees -
Website http://abzena.com/
Updated 09/14/2018
Abzena Plc engages in the provision of proprietary technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It operates through the following segments: Biology, Chemistry, and Biomanufacturing. Its services include: antibody discovery and candidate screening; immunology and immunogenicity assessment; antibody and protein engineering to reduce immunogenicity; and custom synthesis of cytotoxic payloads, reagents, and other small molecules.


View All

Kenneth Thomas Cunningham
Non-Executive Chairman
William John Edward Burt
Chief Executive Officer & Director